Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review

被引:20
|
作者
Dragoman, Monica V. [1 ]
Simmons, Katharine B. [2 ,3 ]
Paulen, Melissa E. [4 ]
Curtis, Kathryn M. [2 ]
机构
[1] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland
[2] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA
[3] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA
[4] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN 46204 USA
关键词
Combined hormonal contraception; Obesity; Contraceptive effectiveness; Oral contraception; BODY-MASS INDEX; NATIONAL-SURVEY; FAILURE; WEIGHT; EFFICACY; COHORT; RISK;
D O I
10.1016/j.contraception.2016.10.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate from the literature whether combined hormonal contraception (CHC), including combined oral contraception pills (COCs), transdermal patch, vaginal ring or combined injectables, have different effectiveness or failure rates by body weight or body mass index (BMI). Study design: We searched PubMed and the Cochrane Library databases for all articles in all languages published between inception and February 2016, for evidence relevant to body weight or BMI, CHC use and contraceptive effectiveness. The quality of each individual study was assessed using the system for evaluating evidence developed by the United States Preventive Services Task Force. Results: From 2874 articles, we identified 15 reports for inclusion, all of fair to poor quality. Fourteen studies measured the association of obesity status and contraceptive failure among COC users. Three fair quality and one poor quality study reported increased COC failure among a heterogeneous population of overweight and obese women compared with normal weight women, while eight fair quality and two poor quality studies did not find an association. Two fair quality studies reported on contraceptive transdermal patches. One pooled analysis described a higher proportion of pregnancies among women using the patch who weighed >= 90 kg; another secondary analysis suggested BMI>30 was associated with increased failure. No studies directly compared contraceptive effectiveness using the combined vaginal ring or combined injectable. Conclusion: Current available evidence addressing the risk of CHC failure in obese compared to normal weight women is limited to fair and poor quality studies. Studies of COCs show mixed results, though absolute differences in COC failure by body weight and BMI are small. Based on limited evidence, it appears that increasing body weight and BMI may contribute to decreasing contraceptive patch effectiveness. (C) 2017 Published by Elsevier Inc.
引用
收藏
页码:117 / 129
页数:13
相关论文
共 50 条
  • [21] Hormonal contraceptive use and vitamin A deficiency among women in Tanzania
    Haile, Zelalem T.
    Teweldeberhan, Asli K.
    Chavan, Bhakti
    Francescon, John
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 141 (01) : 20 - 25
  • [22] Contraceptive use in diabetic and obese women
    Chuang, CH
    Chase, GA
    Bensyl, DM
    Weisman, CS
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 210 - 210
  • [23] Contraceptive use by diabetic and obese women
    Chuang, CH
    Chase, GA
    Bensyl, DM
    Weisman, CS
    WOMENS HEALTH ISSUES, 2005, 15 (04) : 167 - 173
  • [24] SAFETY OF CONTRACEPTIVE USE AMONG WOMEN WITH CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW
    Abarbanell, Ginnie I.
    Honein, Margaret
    Tepper, Naomi
    Farr, Sherry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 949 - 949
  • [25] Progestogen-only contraceptive use among breastfeeding women: a systematic review
    Kapp, Nathalie
    Curtis, Kathryn
    Nanda, Kavita
    CONTRACEPTION, 2010, 82 (01) : 17 - 37
  • [26] Progestogen-only contraceptive use among breastfeeding women: a systematic review
    Phillips, Sharon J.
    Tepper, Naomi K.
    Kapp, Nathalie
    Nanda, Kavita
    Temmerman, Marleen
    Curtis, Kathryn M.
    CONTRACEPTION, 2016, 94 (03) : 226 - 252
  • [27] Safety of contraceptive use among women with congenital heart disease: A systematic review
    Abarbanell, Ginnie
    Tepper, Naomi K.
    Farr, Sherry L.
    CONGENITAL HEART DISEASE, 2019, 14 (03) : 331 - 340
  • [28] Oral manifestations in women using hormonal contraceptive methods: a systematic review
    Rojo, Marta Garcia
    Lloret, Miguel Ramon Pecci
    Girones, Julia Guerrero
    CLINICAL ORAL INVESTIGATIONS, 2024, 28 (03)
  • [29] Oral manifestations in women using hormonal contraceptive methods: a systematic review
    Marta García Rojo
    Miguel Ramón Pecci Lloret
    Julia Guerrero Gironés
    Clinical Oral Investigations, 28
  • [30] Slovenian guidelines for combined hormonal contraceptive use
    Pinter, Bojana
    Korosec, Sara
    Srnovrsnik, Tinkara
    Ogrinc, Urska Bizjak
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (04): : 277 - 288